Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Harry Cockburn

Company backed by Sam Altman gets FDA approval to trial ‘legal ecstasy’

A San Francisco-based biotech company, backed by OpenAI’s Sam Altman, has won government approval to begin clinical trials of a new “safer MDMA”.

The company, Arcadia Medicine, which is developing psychoactive drugs to treat mental health disorders, could deliver early-stage clinical trial results within a year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.